Showing results (61-70 of 185) with videos related to

Sort By:
Pageof 19
Tumori|August 31, 1994
Dose intensification of chemotherapy in advanced breast cancer: a feasibility phase II studyP Pedrazzoli, C Zamagni, A Martoni, et al.
Melanoma Research|October 24, 2002
Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysisB Palermo, R Campanelli, S Garbelli, et al.
American Journal of Clinical Oncology|January 22, 2002
Prospective phase II study of single-agent gemcitabine in untreated elderly patients with stage IIIB/IV non-small-cell lung cancerA Martoni, F Di Fabio, M Guaraldi, et al.
Haematologica|October 6, 1999
Efficacy of epirubicin/paclitaxel combination in mobilizing large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimenC Zibera, P Pedrazzoli, L Ponchio, et al.
Haematologica|May 1, 1996
Circulating progenitor cell collection: experience from 275 leukaphereses in various malignancies and in healthy donorsL Torretta, C Perotti, G Dornini, et al.
British Journal of Haematology|April 12, 2000
Transfusion of platelet concentrates cryopreserved with ThromboSol plus low-dose dimethylsulphoxide in patients with severe thrombocytopenia: a pilot studyP Pedrazzoli, P Noris, C Perotti, et al.
Cancer Treatment Reports|January 1, 1981
Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot studyA Pellegrini, B Massidda, V Mascia, et al.
Bone Marrow Transplantation|March 7, 2003
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantationF F Fagnoni, L Lozza, C Zibera, et al.
Haematologica|October 30, 1998
Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancerP Pedrazzoli, C Perotti, P Noris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancerS Cresta, G Grasselli, M Mansutti, et al.
Pageof 19